Latest News
Genprex, Inc.
- Genprex highlights new peer-reviewed research on TUSC2 tumor suppressor gene
- Genprex (GNPX) Unveils Key Research on TUSC2's Role in Brain Agi
- Form 8K Genprex Inc For: 21 October By Investing.com
- Genprex highlights preclinical study on TUSC2 gene in brain aging By Investing.com
- Genprex Highlights New Preclinical Data Identifying Role of TUSC2, the Gene Used in REQORSA®, in Maintaining Cellular Function During Brain Aging
- Genprex, Inc. (GNPX) Stock Price Prediction for 2026, 2030-2040
- Genprex Inc. (GNPX) Stock Rises 1.72% to $2.65 as Shares Push Toward Upper Range - MFI Overbought
Headlines from the last 30 days, linking to the original publishers. See all market news →